The Department of Veterans Affairs intends to enter into a sole source contract with Lantheus Holdings Inc. for the procurement of Pylarify (Piflufolastat) F-18 PSMA, a specialized radiopharmaceutical product essential for imaging in prostate cancer diagnosis. This contract, managed by the Networking Contracting Office in Newington, CT, aims to support the VA Boston Healthcare System's West Roxbury and Jamaica Plain campuses by ensuring timely delivery of USDA and USP approved radiopharmaceuticals, compliant with Nuclear Regulatory Commission licensing requirements. Interested parties that believe they can fulfill this requirement must submit their capabilities in writing by December 27, 2024, to the designated contracting specialist, Jerry Choinski, at jerry.choinski@va.gov. This notice serves as an expression of intent rather than a formal solicitation, and the government retains discretion over whether to open this procurement for competition based on the responses received.